Navigation Links
Innophos Holdings, Inc. Reports Fourth Quarter And Full Year 2012 Results
Date:2/14/2013

t of changes in tons sold at the relative prices applicable to the variation in tons, otherwise known as volume/mix.

The following tables illustrate for the three months ended December 31, 2012 the percentage changes in net sales by reportable segments and by Specialty Phosphates product lines compared with the same period of the prior year, including the effect of selling price and volume/mix changes upon revenue: Reportable Segments  PriceVolume/Mix  TotalSpecialty Phosphates US & Canada

-0.1%3.8%3.7%Specialty Phosphates Mexico

-5.0%-5.8%-10.8%Total Specialty Phosphates

-1.5%1.0%-0.5%GTSP & Other

-11.7%13.9%2.2%Total

-2.7%2.5%-0.2%Note: Includes Kelatron/AMT benefit of 3.6% in Specialty Phosphates US & Canada Volume/Mix and 2.6% in Total Specialty Phosphates Volume/MixSpecialty Phosphates Product Lines  PriceVolume/Mix  TotalSpecialty Ingredients

-1.1%-0.6%-1.7%Food & Technical Grade PPA

-4.7%8.1%3.4%STPP & Detergent Grade PPA

1.5%-1.5%0.0%Note: Includes Kelatron/AMT benefit of 3.9% in Specialty Ingredients Volume/MixSummary Profit & Loss Statement – Full Year INNOPHOS HOLDINGS, INC. AND SUBSIDIARIESCondensed Consolidated Statement of Operations (Unaudited)(Dollars In thousands, except per share amounts or share amounts) Year Ended December 3120122011Net sales

$862,399$810,487Cost of goods sold

684,979605,172Gross profit

177,420205,315Operating expenses:Selling, general and administrative

64,32065,380Research & development expenses

3,1072,923Total operating expenses

67,42768,303Operating income

109,993137,012Interest expense, net

5,9775,726Foreign exchange (gain) loss

(1,957)875Income before income taxes

105,973130,411Provision for income taxes

31,78343,889Net income

$74,190$86,522Dilu
'/>"/>

SOURCE Innophos Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter And Full Year 2012 Results
2. Innophos To Present At 2012 KeyBanc Capital Markets Basic Materials & Packaging Conference
3. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
4. Free Research Report on Laboratory Corp. of America Holdings, Sony Corp., Cyberonics, Inc., Olin Corp. and Deluxe Corp.
5. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
6. Zacks Sell List Highlights: J.C. Penney, Spirit AeroSystems Holdings, The New York Times and Jazz Pharmaceuticals
7. China Pharma Holdings, Inc. Reports Third Quarter 2012 Financial Results
8. Zimmer Holdings, Inc. Reports Third Quarter 2012 Financial Results
9. China Pharma Holdings, Inc. Reports Second Quarter 2012 Financial Results
10. RxAlly Member Pharmacies Invited To Become The Preferred Network For Smart Insurance Company Holdings, Inc.
11. InfuSystem Holdings, Inc. Reports $14.1 Million of Revenues for the Second Quarter of 2012; Announces Annualized Cost Savings in Excess of $1 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Sarnova, parent company ... of the new www.tri-anim.com website, continuing ... healthcare distributor of respiratory, anesthesia and other critical ... The site has many new features ... making online shopping and ordering easier and more ...
(Date:3/2/2015)... , March 2, 2015  Tandem Diabetes Care®, Inc. ... and manufacturer of the t:slim® and t:flex™ Insulin Pumps, ... public offering of common stock have exercised their option ... stock at a price to the public of $11.50 ... offering is expected to be $64.8 million, after deducting ...
(Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
Breaking Medicine Technology:Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3
... Sept. 13, 2011 Kremers Urban Pharmaceuticals Inc. is ... dismissing all pending litigation arising from its Abbreviated New ... hydrochloride product, for which Concerta® is the reference listed ... The settlement includes a patent license ...
... Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that ... will present at the Sixth Annual JMP Securities Healthcare Conference ...  The conference will be held at the St. Regis hotel ... the presentation can be accessed through the investor relations section ...
Cached Medicine Technology:Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 2
(Date:3/2/2015)... March 02, 2015 Getting customers to ... is the goal this March as the 31st annual ... by the National Frozen & Refrigerated Foods Association (NFRA) ... Ian’s offers more than 20 delicious frozen selections and ... , The tasty frozen options are crafted with simple ...
(Date:3/2/2015)... Diego, CA (PRWEB) March 02, 2015 ... in personal injury, is partnering with Doctors on ... to more patients. It’s rare for personal injury ... same office and especially on a lien basis. However, ... with its outstanding team of chiropractors, M.D., pain management ...
(Date:3/2/2015)... Monroeville, PA (PRWEB) March 02, 2015 ... part of the Allegheny Health Network, are ... with new software called Visual Info Zonal Reminder (VIZR), ... , Introduced in 2013, Google Glass is a wearable ... in a smartphone-like hands-free format. Wearers communicate with the ...
(Date:3/2/2015)... 2015 A cocaine snorting Oscar ... the typical nip slip or scathing scuffle. A new ... dawning the streets of Hollywood as Paper Jesus’ rendition ... addiction and substance abuse in Hollywood. The Oscar statue ... a political stance on the travails of drug addiction ...
(Date:3/2/2015)... March 02, 2015 Just months ... warned against the use of power morcellators ( ... removal surgeries, insurer UnitedHealthCare is poised to restrict ... those devices. In a notification sent to physicians ... April, it would require pre-authorization for laparoscopic or ...
Breaking Medicine News(10 mins):Health News:Take a Fresh Look at Frozen with Ian’s 2Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4
... year, the higher the survival rate, study finds , , ... at least 20 lung transplants a year have the ... Johns Hopkins researchers. , They said their findings could ... hospitals nationwide. , The researchers analyzed data from the ...
... Services Group, of Wayne, PA,announces the completion of ... program on January 26, 2009, making it the ... receive,certification from ISSA, the worldwide cleaning industry association. ... , CIMS is a ...
... Recent studies suggest that human breast cancer risk ... such as during hormone replacement therapy. Now, a University ... drug that targets the most common mutated gene, p53, ... chemotherapeutic treatment for progestin-accelerated human breast cancer. , ...
... community-based,oncologist in Billings, Montana, has been elected president of ... cancer patients and,professionals. , "It,s ... for the next year," said Dr.,Cobb, who is managing ... Montana. "Community cancer care faces severe challenges,and I,m looking ...
... Savvy Self-Funding,Healthcare Conference and Expo will provide employers and ... during a June 1-3, 2009,conference in Kansas City, Missouri. ... as it is designed and sponsored by an actual,employer ... SPHR, Director of Human,Resources, created the event to help ...
... had more multiple drug-resistant strains than their pets , , WEDNESDAY, ... sleep with them or allow them to lick their faces ... the same strains of E. coli bacteria as their dogs, ... a clinical assistant professor at the university,s College of Veterinary ...
Cached Medicine News:Health News:Lung Transplant Outcomes Better at High-Volume Hospitals 2Health News:Crothall First in Healthcare to Achieve CIMS Certification 2Health News:Crothall First in Healthcare to Achieve CIMS Certification 3Health News:Breast cancer drug shows promise for treating, preventing progestin-dependent tumors 2Health News:Dr. Patrick Cobb Named President of Community Oncology Alliance 2Health News:Employer Designed Self-Insured Healthcare Conference Offers Unique Perspective 2Health News:In the World of Germs, Man Bites Dog 2
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
... test kit is a solid phase enzyme ... is designed for the quantitative measurement of ... serum or plasma. The microplate is coated ... and patient samples are pipetted into the ...
Free T3 EIA Thyroid Function 025-BC-1006...
Prolactin EIA Reproductive Markers 025-BC-1037...
Medicine Products: